Xiao-Chun Cao: Wait Listed Xiao-Chun Cao shelves stood a dark horse camp she and entrepreneurs players pictured. Photo Cao sowed a smiling face, but the face looks slightly more swollen, Cao said with a smile, 'It was puffiness.' Photo was taken in September 2010, when she was just the end of chemotherapy. Until six months, 42-year-old Cao was diagnosed with breast cancer. Before entering the operating room, she had written a suicide note. Now her body recover very well, Tiger Pharmaceutical IPO also will be successful too. 'With my ability, this is just fine, and I'm also very satisfied.' Cao said. Xiao-Chun Cao is the co-founder of Tiger medicine. Tiger medicine is a CRO (contract research organization) Company (see note). For many people, CRO is an unfamiliar word on the SFC website published the 'gem release supervision unit IPO situation reporting companies basic information table' (as "sailor moon cosplay " of January 31, 2012), which the art is the inclusion of scientific and technological achievements into service, became the laughing stock of the industry. CRO born in the 1970s, but until the last decade, only to the rapid development in the country. Xiao-Chun Cao and never thought CRO CRO will enter the field. Since its own ideals, she always wanted to become a doctor, and therefore apply for medical school. In hospital practice day, she had the opportunity to stand together with the doctor in the operating room, with the doctors surgery, which she did not have a sense of accomplishment to produce those days also become in the future memories.
Xiao-Chun Cao did not make the hospital school, but is recommended to enter the Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (East China Pharmaceutical). [Quote2] 'How many shares does not make cosplay costumes for sale sense,' Cao said, 'can the company do it, is the biggest benefit. You get much more does not necessarily account for the shares. I'm a little less, so that leaves a major controversy to do this, The company will do it. I always felt on my own is certainly impossible to do. '[/ quote2] Two years later, Xiao-Chun Cao switched to a subsidiary of Hangzhou East China Pharmaceutical Jiuyuan Gene Engineering Co., Ltd. (hereinafter referred to nine sources) because the person in charge of the phrase 'Come on over, I would later open a hospital, then you can be a doctor.' Of course she could not as a doctor. Although once he broke a medicine cabinet, and occasionally you can help people doing acupuncture, massage, but her most important job is to make the drug in clinical trials for nine sources.
In the process of doing the project, Cao met in Roche inauguration Ye Xiaoping. For Ye, Cao used to call 'Ye Bo', whenever the project hassle, Xiao-Chun Cao always to Ye Bo for help. In her view, Bo Ye is her teacher. Also in Jiuyuan, Cao first time that a CRO. A source of nine clinical program with Singapore-based CRO companies to cooperate. At that time, there is little domestic pharmaceutical company to do your clinical CRO. That cooperation, Cao saw the foreign CRO company's standard, domestic pharmaceutical companies rarely able to meet this standard. This gap she saw efforts. In 2002, Xiao-Chun Cao nominal age 34, plans to leave nine sources. After the entrance, according to the rural folk, the family had asked the village's 'blind' to her fortune. 'Blind,' said she would have after 35 years of business operation. Cao's father was a local person in charge of township enterprises, 80 years in the last century, rural run from Jinhua brewery, soybean processing plant, and formed a project team, many young people have to go to work near Cao father's factory to go, This allows the number of Cao also believes that he has some business gene. However, Cao college, his father died of illness, factories have closed down, the engineering team also disbanded. She wanted to father must want to see their hard-built factories fallen. 'If he is more to be a decade or two, it should be doing great.' 'I always wanted to do some things, inherited some of his wishes.' Cao know their food, engineering and other industries are not familiar with, she can only choose their own familiar with the industry over the past decade, all of her experience in the clinical trials. She resigned venture into the realm of ideas CRO told her trust leaves Bo, Bo Ye got support. They share in half, Tiger Consulting Co., Ltd. was established. Cao soon found the first client - her old club Huadong Pharmaceutical. Huadong Pharmaceutical was a clinical project has been a year, progress has been extremely difficult, Cao whom redesigned the program and succeeded in reducing the number of cases. This not only saves time for the Huadong Pharmaceutical, also saves $ 1.2 million clinical. Second customer follow soon. Tianjin Institute of medicine for clinical hepatitis drugs needs to be done. Tiger took over the project when another company of similar products in the clinic, whose products can be first approved, who will be able to seize market opportunities. Finally, in Tiger's elaborate design, research products available a year earlier than its competitors.
This one has laid a Tiger this new company reputation in the circle. Hepatitis project attracted several companies to come to, until 2007, the Tiger, have not been established BD department. In 2003, Tiger incumbent medicine, medical director Shi Xiaoli home, join Tiger advice. Equity need to be reassigned. Soon, Ye Bo from Roche departure, officially joined the Tiger. In 2004, Tiger medicine was established in the new company, Cao leaves about 1/3 of the shares, no longer half. 'How many shares does not make sense,' Cao said, 'can the company do it, is the biggest benefit. You do not necessarily get more shares accounted for more. I little bit, so that leaves a major controversy to do this, the company only would do it. I always felt on my own is certainly impossible to do. 'After Bo Ye chance to enter, leading the company's medical projects. Tiger existing medical team, responsible for management by Bo Ye, Xiao-Chun Cao turned to administration, finance and personnel. Cao nine days to do the project source, because there is no reference standard available, most of the time in the hospital of his own blood to the subject, testing, after completion of the relevant statistics themselves, which is when the domestic pharmaceutical practice. In 1999, China promulgated GCP, government regulators strengthen the regulatory requirements of clinical trials, but the implementation is not in place. A large pharmaceutical company experience leaves Bo and returnees have joined a Tiger team gradually standardized operation and management, this specification Tiger won the subsequent development of a good opportunity. 'Our development with the country's trade policy is closely related.' Cao said. After the promulgation of GCP, CRO company began to appear. In 2007, the pharmaceutical industry R \u0026 D order rectification, many clinical finish registration project because clinical trials are not standardized and pass approval. This caused panic pharmaceutical companies began to pay attention to the normative clinical trials, and to seek cooperation with the relative standard CRO companies. 'Before that, the industry is a mess, non-standard business can make money, because of the low cost, data false, and we have high costs, so their development is certainly better than us. Reorganization that began in 2007 is very favorable for us , doing standard business was valued, pharmaceutical companies would rather spend more money to us to do. 'During these years, Tiger has gradually from clinical generic drugs, clinical steering innovative drugs, and began looking for international clients. 2008, Qiming create betting information Tiger, Tiger completed the acquisition of US-Star. 'Beauty Star is an international multi-center clinical do, are international clients, which is precisely the missing Tiger. Our own to do this is very difficult, do not have the people to do high-end statistical analysis, customers will not identity. 'Cao said. [Quote2] face smooth communication with overseas customers, many colleagues, Cao occasionally inferiority complex about. She figured the second half of this year to the US study period, the things that have to learn a science school. In those days, the dark horse camp, she met Wang. Wang at this age choose to go to Harvard education, her very touching. [/ Quote2] With China's economic development, multinational strategic focus to shift to China, under the pressure of huge R \u0026 D costs, pharmaceutical companies are also seeking to cooperate with the appropriate CRO companies. 'Chinese and foreign customers to find CRO companies, the requirement is very strict, often go through 2--3 years of inspection time, customers will have Tiger after the strict inspection processes in order to obtain the supply of qualified customers only likely to. some less important business starting with Tiger cooperation with overseas customers face smooth exchange of many colleagues, Cao occasionally inferiority about. She figured this year to the United States for some time training, learning things that are learned One school in those days horse camp, she met Wang. Wang at this age choose to go to Harvard education, her very touching. With the development of the Tiger, the world's largest CRO company Quintiles came to the door.
For cooperation, Tiger initially enthusiastic, and actively cooperate with the due diligence. But on balance, Tiger rejected the cooperation acquisitions in this area is not new. When set up as early as the Tiger, according to Rodriguez, KendleWits etc. The company has set up in 2009 according to Rodriguez was acquired by PPD;.. 2011 年 KendleWits was 爱尔兰爱康 Clinical Research (ICON plc) to acquire, 'I have not been abroad, and rather old-fashioned,' Cao said, 'From the creation of The company since, I felt and this is the Chinese company, can not become abroad. 'In 2005, Xiao-Chun Cao to Tiger developed vision: to do the best domestic CRO company now, this vision has been realized sitting in his office, Cao revealed a vision for the next Tiger, and make the best of Asia-Pacific. CRO company Note:. CRO (Contract Research Organization):. is an academic or commercial scientific institutions and individuals responsible for implementing all or part of the activities involved in drug research and development process as an emerging industry, CRO originated in the 20th century the United States, the CRO company can only provide early 70s for pharmaceutical companies with limited drug analysis service starting from the 1980s, with the US FDA drug regulations of continuous improvement, drug discovery process correspondingly more complex, more and more pharmaceutical companies are part of the work will be transferred to the CRO completed.
After several years of development, CRO industry already has a relatively complete technical service system, provide technical services covering almost the entire process of drug discovery and development, has become Pharmaceutical R \u0026 D chain indispensable part of Chen Haozhi:. 'Entrepreneur' dark horse camp one, my students the same period ah hope we can give the cattle Wenwen, 'Entrepreneur' magazine surprise Xiaochun super tough, but usually. Xiao-Chun Cao is the least speak: Thank you concern, support and love air gear cosplay of friends Tiger Tiger medicine lP0 was successful too this afternoon at 17:19 on April 10, 2012 Xiao-Chun Cao:!! Today is an isolated illness Anniversary this year, after almost six months of therapy, surgery, chemotherapy, radiotherapy, experience fear, despair, loss, hope, etc. mentality also have the opportunity to participate in the growing dark horse camp, he made many friends and learned a lot of ideas! in This encouraged me to thank all the way to care for family members, doctors and friends. At the same time I wish everyone and myself healthier, happier! at 08:41 on March 9, 2011